← AlphaSignal

SOLV

★★☆☆☆ Passmistral

Solventum Corporation

Healthcare · sector percentile 31

세션 움직임

$91.25

+$1.68+1.88%

거래량 0.86× 평균

51/100 quant · tgt $93.92

ADV$ 114.9M

세션 2026-08-24 · 스냅샷 — 실시간 호가 아님

직전 스캔 대비

2026-08-21 → 2026-08-25

점수-0.1가격+$2.64 · +2.98%

참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.

스냅샷 시세

세션 2026-08-24 · 스캔 2026-08-25 · 푸시 08-24 18:09 ET · 애프터아워 (오래됨)

시세 상세 보기
종가/스캔가
$91.25
전일 종가
$89.57
푸시 최신가
$91.25 (오래됨) · 08-24 18:09 ET · 애프터아워
세션 시가
$89.45
직전 세션 범위
$89.36 – $91.51
52주 범위
$78.77 – $91.51
세션 거래량
1,144,696
평균 거래량 (20일)
1,324,484
시가총액
$15.53B
PER (TTM)
10.95
Forward PER
12.63
배당 수익률
0.00%
1년 목표가 추정
$93.92
다음 실적

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.

시장 브리핑

선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.

이 종목의 최근 헤드라인이 없습니다.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — Solventum's healthcare solutions leverage strong organic revenue growth (2.2% YoY) and improving EPS (3.9% YoY) with a trailing P/E of 10.95x, signaling undervaluation relative to peers.
  • Risks — High debt-to-equity ratio (110.3x) and low free cash flow margin (5.9%) may constrain financial flexibility and growth investments.
  • Target Upside — Mean price target of $93.92 implies ~2.9% upside from current $91.25, aligning with modest analyst consensus.

Score History

2026-07-3150.7 pts · 2026-08-25

16 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-08-25$91.25+$2.6450.7Pass
  • 2026-08-21$88.61+$0.8050.8Pass
  • 2026-08-20$87.81+$0.3650.7Pass
  • 2026-08-19$87.45+$0.6351.8Pass
  • 2026-08-18$86.82−$1.7752.5Pass
  • 2026-08-17$88.59+$2.1344.4Pass
  • 2026-08-14$86.46+$0.1051.1Pass
  • 2026-08-13$86.36+$2.2651.1Pass
  • 2026-08-12$84.10−$1.1152.5Pass
  • 2026-08-11$85.21+$2.2552.1Pass
  • 2026-08-07$82.96−$4.5153.0Pass
  • 2026-08-06$87.47−$0.4743.4Pass
  • 2026-08-05$87.94−$0.1343.4Pass
  • 2026-08-03$88.07+$2.6343.4Pass
  • 2026-08-01$85.44+$0.1943.4Pass
  • 2026-07-31$85.2543.4Pass

Quant Breakdown

Revenue Growth
0.9
EPS Growth
1.6
ROE
12.0
PER Relative
10.0
Debt / Equity
4.8
FCF Margin
3.1
Analyst Upside
1.0
Insider / Sector
2.0
Momentum 3M
11.5
Earn. Surprise
3.8

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

Elevated vs 20das of 2026-08-21 · finra_cnms
Short / total
58.9%
vs 20d (z)
1.78
Short vol
199,644
Status
ok

Squeeze pressure score

full

56/100

Short leg
47
Call leg
85
Activity
0.3
Call vol share
82.5%
PCR (vol)
0.21
Call OI share
ATM IV
0.0%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

공시 점수 (Disclosure)

캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.

점수 창에 최근 SEC 공시·실적 일정 입력이 아직 없습니다.

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

실적 서프라이즈 (퀀트 맥락)

최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.

최근 보고 서프라이즈 +0.0%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-18·sec_edgar·CIK 0001964738
Next earnings
2026-11-05yahoo_calendar
Last earnings

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.